These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30017901)

  • 61. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis.
    Walther A; Breidenstein J; Miller R
    JAMA Psychiatry; 2019 Jan; 76(1):31-40. PubMed ID: 30427999
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Testosterone and depression: systematic review and meta-analysis.
    Zarrouf FA; Artz S; Griffith J; Sirbu C; Kommor M
    J Psychiatr Pract; 2009 Jul; 15(4):289-305. PubMed ID: 19625884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of testosterone treatment on circulating irisin in men with late-onset hypogonadism and metabolic syndrome.
    Assyov Y; Gateva A; Karamfilova V; Gatev T; Nedeva I; Velikova T; Kamenov ZA
    Aging Male; 2020 Dec; 23(5):1381-1387. PubMed ID: 32456511
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical characteristics and comorbidities associated with testosterone prescribing in men.
    Sharma A; Ul-Haq Z; Sindi E; Al-Sharefi A; Kamalati T; Dhillo WS; Minhas S; Jayasena CN
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):227-235. PubMed ID: 34816471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
    Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
    J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy.
    Ide V; Vanderschueren D; Antonio L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375030
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
    Bhasin S; Lincoff AM; Nissen SE; Wannemuehler K; McDonnell ME; Peters AL; Khan N; Snabes MC; Li X; Li G; Buhr K; Pencina KM; Travison TG
    JAMA Intern Med; 2024 Apr; 184(4):353-362. PubMed ID: 38315466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Testosterone replacement therapy in males with erectile dysfunction.
    Jacob BC
    J Pharm Pract; 2011 Jun; 24(3):298-306. PubMed ID: 21676853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gaps in Patient Knowledge About Risks and Benefits of Testosterone Replacement Therapy.
    Gilbert K; Cimmino CB; Beebe LC; Mehta A
    Urology; 2017 May; 103():27-33. PubMed ID: 28238756
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
    Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
    Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?
    Awouters M; Vanderschueren D; Antonio L
    Andrology; 2020 Nov; 8(6):1590-1597. PubMed ID: 31696669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Marketing and Testosterone Treatment in the USA: A Systematic Review.
    Bandari J; Ayyash OM; Emery SL; Wessel CB; Davies BJ
    Eur Urol Focus; 2017 Oct; 3(4-5):395-402. PubMed ID: 29174614
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
    Seidman SN; Spatz E; Rizzo C; Roose SP
    J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
    Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
    Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
    Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions.
    Aydogan U; Aydogdu A; Akbulut H; Sonmez A; Yuksel S; Basaran Y; Uzun O; Bolu E; Saglam K
    Endocr J; 2012; 59(12):1099-105. PubMed ID: 22972022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.